Sophie Paczesny

Pediatric Blood and Marrow Transplant Program, University of Michigan

Research Area

Biography

Sophie Paczesny has not added Biography.
If you are Sophie Paczesny and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 14	2012

Other Publications

Article	Year
Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Annals of the New York Academy of Sciences\| PubMed ID: 12727638	2003
Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 12973032	2003
Dendritic cells as vectors for immunotherapy of cancer. Seminars in cancer biology\| PubMed ID: 15001163	2003
Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. The Journal of experimental medicine\| PubMed ID: 15173207	2004
Measuring melanoma-specific cytotoxic T lymphocytes elicited by dendritic cell vaccines with a tumor inhibition assay in vitro. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 15725959	2005
Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanoma. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 15725960	2005
Immunotherapy via dendritic cells. Advances in experimental medicine and biology\| PubMed ID: 15932026	2005
Spontaneous proliferation and type 2 cytokine secretion by CD4+T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells. Journal of clinical immunology\| PubMed ID: 15981095	2005
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells. Cancer immunology, immunotherapy : CII\| PubMed ID: 16331519	2006
Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment. Journal of leukocyte biology\| PubMed ID: 17229904	2007
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood\| PubMed ID: 18042798	2008
Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18209056	2008
Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. Journal of proteome research\| PubMed ID: 18311905	2008
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood\| PubMed ID: 18502834	2008
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 18541194	2008
A biomarker panel for acute graft-versus-host disease. Blood\| PubMed ID: 18832652	2009
Plasma biomarkers in graft-versus-host disease: a new era? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 19147075	2009
Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome medicine\| PubMed ID: 19402886	2009
Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Current stem cell research & therapy\| PubMed ID: 19500066	2009
Acute graft-versus-host disease: new treatment strategies. Current opinion in hematology\| PubMed ID: 19812490	2009
Postmenopausal estrogen and progestin effects on the serum proteome. Genome medicine\| PubMed ID: 20034393	2009
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 20302964	2010
Elafin is a biomarker of graft-versus-host disease of the skin. Science translational medicine\| PubMed ID: 20371463	2010
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome medicine\| PubMed ID: 20667078	2010
Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease. Immunotherapy\| PubMed ID: 21091111	2010
Translational research efforts in biomarkers and biology of early transplant-related complications. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21195297	2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies. Blood\| PubMed ID: 21841163	2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood\| PubMed ID: 21979939	2011
Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoi... Current stem cell research & therapy\| PubMed ID: 22023620	2012
Clinical applications for biomarkers of acute and chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22226094	2012
Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood\| PubMed ID: 22286196	2012
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood\| PubMed ID: 22383800	2012
TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22469883	2012